PCSK9 (Bococizumab Biosimilar) Antikörper (Biotin)
-
- Target Alle PCSK9 (Bococizumab Biosimilar) Produkte
- PCSK9 (Bococizumab Biosimilar)
- Reaktivität
- Human
-
Wirt
-
Humanized
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser PCSK9 (Bococizumab Biosimilar) Antikörper ist konjugiert mit Biotin
-
Applikation
- Flow Cytometry (FACS)
- Verwendungszweck
- Biotinylated Anti-PCSK9(bococizumab biosimilar) mAb
- Isotyp
- IgG2
-
-
- Applikationshinweise
- Flow Cyt 1:100
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Buffer
- Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
-
- Target
- PCSK9 (Bococizumab Biosimilar)
- Andere Bezeichnung
- bococizumab Biosimilar (PCSK9 (Bococizumab Biosimilar) Produkte)
- Substanzklasse
- Biosimilar
- Hintergrund
-
Synonyms Target:FH3,FHCL3,HCHOLA3,LDLCQ1,NARC-1,NARC1,PC9
Synonyms Antibody:PF-04950615, RN-316, RN316
-